Ocomystin eye drops vial-cap 0.01% 10ml
Condition: New product
979 Items
Rating:
Be the first to write a review!
More info
Active ingredients
Benzyldimethyl myristoylamino propylammonium
Release form
Drops
Composition
Active ingredient: Miramistin Concentration of active ingredient (mg): 0.1 mg
Pharmacological effect
An antiseptic preparation for topical use in ophthalmology. It has a pronounced antimicrobial effect against gram-positive and gram-negative, aerobic and anaerobic bacteria in the form of monocultures and microbial associations, including hospital strains with polyresistance to antibiotics. It is active against chlamydia, pathogenic fungi, and has a lot of bacteria. herpes, adenoviruses. The drug is more effective against gram-positive bacteria, including staphylococci, streptococci. Under the action of the drug, the resistance of bacteria and fungi to antibiotics is reduced.
Pharmacokinetics
Data on the pharmacokinetics of the drug Okomistin not provided.
Indications
Okomistin is intended for the treatment of patients suffering from acute and chronic conjunctivitis, blepharoconjunctivitis, keratouveitis and bacterial keratitis, viral and fungal etiology. Okomistin can be prescribed for chemical and thermal eye burns, in the complex treatment of eye injuries. The drug is also used as a preventive agent for conducting surgical interventions in ophthalmic practice.
Contraindications
Okomistin is not prescribed to patients with individual intolerance to Miramistina. Eye drops should not be given to pregnant and lactating women. Okomistin should not be used in pediatric practice. You should refrain from controlling potentially unsafe mechanisms and driving the car for at least 30 minutes after instillation of the droplets into the conjunctival bag.
Precautionary measures
Do not exceed recommended doses.
Use during pregnancy and lactation
The drug is contraindicated for use during pregnancy and lactation (breastfeeding).
Dosage and administration
Okomistin is intended for local use. The solution should be instilled in the conjunctival sac. Wash hands before use. When using the drug Okomistin should avoid contact with the tip of the dropper with the mucous membrane of the eyes, eyelashes and skin.The duration of therapy and the pattern of use of the drug Okomistin is determined by the doctor. For the treatment of infectious and inflammatory diseases of the eye, as a rule, 1-2 drops of the drug Okomistin are prescribed in the affected eye from 4 to 6 times a day. Drops should be used until complete recovery. As a prophylactic, as a rule, 1-2 drops of Okomistin are prescribed in each eye three times a day. The recommended duration of use of the drug Okomistin is 2-3 days before the planned surgical intervention and 10-15 days after the operation. In case of thermal and chemical burns of the eye Okomistin is prescribed after washing the eye 1-2 drops of the drug every 5-10 minutes (for 1- 2 hours), after which they switch to the use of the drug Okomistin in the form of baths. Contact lenses should be removed before using the drug Okomistin and wear no earlier than 10-15 minutes after instillation of the drops in the conjunctival sac.
Side effects
Okomistin is generally well tolerated by patients. In some cases, the development of irritation, itching and redness of the eye immediately after instillation of eye drops was noted.
Overdose
Data on drug overdose Okomistin not provided.
Interaction with other drugs
Studies of the interaction of the drug Okomistin with other drugs was not conducted.
special instructions
Contact lenses should be removed immediately before instillation of the drug Okomistin and wear no earlier than 15 minutes after instillation. Effect on the ability to drive vehicles and control mechanisms During the period of treatment, you must refrain from driving vehicles and from engaging in other potentially dangerous activities that require increased concentration of attention, speed of psychomotor reactions and good vision, within 30 min after instillation into the eye.